NL960017I2 - Expressie van Factor VIII-activiteit in zoogdiercellen. - Google Patents

Expressie van Factor VIII-activiteit in zoogdiercellen.

Info

Publication number
NL960017I2
NL960017I2 NL960017C NL960017C NL960017I2 NL 960017 I2 NL960017 I2 NL 960017I2 NL 960017 C NL960017 C NL 960017C NL 960017 C NL960017 C NL 960017C NL 960017 I2 NL960017 I2 NL 960017I2
Authority
NL
Netherlands
Prior art keywords
factor
nucleotide sequence
proteins
expression
mammalian cells
Prior art date
Application number
NL960017C
Other languages
English (en)
Other versions
NL960017I1 (nl
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24909926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL960017(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NL960017I1 publication Critical patent/NL960017I1/nl
Publication of NL960017I2 publication Critical patent/NL960017I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL960017C 1985-04-17 1996-07-09 Expressie van Factor VIII-activiteit in zoogdiercellen. NL960017I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72431185A 1985-04-17 1985-04-17

Publications (2)

Publication Number Publication Date
NL960017I1 NL960017I1 (nl) 1996-10-01
NL960017I2 true NL960017I2 (nl) 1997-02-03

Family

ID=24909926

Family Applications (1)

Application Number Title Priority Date Filing Date
NL960017C NL960017I2 (nl) 1985-04-17 1996-07-09 Expressie van Factor VIII-activiteit in zoogdiercellen.

Country Status (4)

Country Link
US (1) US8603777B1 (nl)
NL (1) NL960017I2 (nl)
RU (1) RU2122583C1 (nl)
ZA (1) ZA862768B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
KR101013697B1 (ko) * 2002-05-01 2011-02-10 바이엘 쉐링 파마 악티엔게젤샤프트 항응고제로서의 조직 인자 표적화된 신규 트롬보모둘린융합 단백질
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
RU2448160C1 (ru) * 2010-11-11 2012-04-20 Закрытое акционерное общество "ГЕНЕРИУМ" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pAP271, КОДИРУЮЩАЯ ПОЛИПЕПТИД ФАКТОРА VII СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА, И ЛИНИЯ КЛЕТОК Mesocricetus auratus ВНК 21 k.13 (2H7) - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ФАКТОРА VII СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4459288A (en) 1981-05-11 1984-07-10 Baxter Travenol Laboratories, Inc. Therapeutic blood clotting factor compositions and their use
US4382083A (en) 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4456591A (en) 1981-06-25 1984-06-26 Baxter Travenol Laboratories, Inc. Therapeutic method for activating factor VII
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB2215409A (en) * 1988-02-29 1989-09-20 Deere & Co Seals for bearings in baling machines
WO2006014899A2 (en) * 2004-07-26 2006-02-09 Dow Global Technologies Inc. Process for improved protein expression by strain engineering

Also Published As

Publication number Publication date
NL960017I1 (nl) 1996-10-01
ZA862768B (en) 1986-12-30
US8603777B1 (en) 2013-12-10
RU2122583C1 (ru) 1998-11-27

Similar Documents

Publication Publication Date Title
ES8800343A1 (es) Un metodo para producir una proteina que contiene actividad biologica para coagulacion de sangre, mediada por factor viia
DK0624199T3 (da) Fremgangsmåder til fremstilling af thrombin
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
DE3786321D1 (de) Expression von protein-c.
DE69131580D1 (de) GDF-1 und UOG1 Proteine
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
ATE484587T1 (de) Ldcam genannte moleküle
ATE105480T1 (de) Thrombin bindende substanz und verfahren zu ihrer herstellung.
ATE211390T1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
NL960017I2 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
DE3650477T2 (de) Produktion von Cystinreste enthaltenden aktiven Proteinen
IT1186750B (it) Vettore di clonaggio,molecole di dna ricombinante,ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.